VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE

VARICELLA: OPPORTUNITIES OF FIGHTING WITH «OLD ENEMY» IN PEDIATRIC PRACTICE

Okavax is the first vaccine (based on strain Oka) against varicella in the world. It has high immunogenicity, provides maximally prolonged defence due to forming of cell immunity. Thus, Okavax is efficient against severe varicella. Efficiency of this vaccine is confirmed with results of studies duri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Voprosy sovremennoĭ pediatrii 2010-01, Vol.9 (5), p.99-102
1. Verfasser: M.G. Galitskaya
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Okavax is the first vaccine (based on strain Oka) against varicella in the world. It has high immunogenicity, provides maximally prolonged defence due to forming of cell immunity. Thus, Okavax is efficient against severe varicella. Efficiency of this vaccine is confirmed with results of studies during 20 years. Okavax has good tolerability; it can be recommended to all patients after 12 months old, especially to patients from risk groups. Key words: children, varicella, vaccination. (Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(5):99-102)
ISSN:1682-5527
1682-5535